Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-014648
Filing Date
2013-03-12
Accepted
2013-03-12 18:30:27
Documents
1
Period of Report
2013-03-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v337975_4.html 4  
1 OWNERSHIP DOCUMENT v337975_4.xml 4 15701
  Complete submission text file 0001144204-13-014648.txt   17302
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ALROV TOWER 46 ROTHSCHILD BLVD TEL AVIV L3 66883
Business Address
Akirov Alfred (Reporting) CIK: 0001434514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 13685545